Search - tctmd.com

Displaying 601 - 620 of 764

Sort: Relevancy | Date

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Daily News

Las Fracturas del Stent Persisten en los Dispositivos de Nueva Generación

Jason Kahn

October 02, 2012

Presentation

Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent (EES) Implantation

Presenter: Shoichi Kuramitsu

October 01, 2012

News Daily News

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

September 19, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Daily News

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

Caitlin E. Cox

August 16, 2012

News Daily News

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

L.A. McKeown

July 30, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

Presentation

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Presenter: Takeshi Kimura

July 27, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

Advertisement

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Stent Fractures Persist Among Newer-Generation Devices

Las Fracturas del Stent Persisten en los Dispositivos de Nueva Generación

Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent (EES) Implantation

Un Registro Coreano Confirma la Superioridad de los Stents liberadores de Everolimus sobre los de Zotarolimus

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

SORT OUT IV: El Xience Aguanta el Tirón del Cypher en la Prevención de la Trombosis del Stent

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Meta Análisis: Los SLF son Aceptables aunque No están Exentos de Problemas en la Enfermedad del Tronco Coronario Izdo

Se Publica el RESET: Eficacia y Seguridad Parecidas con SLE y SLS al cabo de 1 Año

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Xience V Noninferior to Cypher for Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content